CD8A and non-small cell lung carcinoma: The MANAscores of CD8+ TIL exhibited substantial variability across patient’s tumors, with the mean MANAscore_i and MANAscore_ni ranging from 0.205 in NSCLC patient NY016-015 to 0.718 inpatient MD01-010 (Supplementary Fig. 3).